Back to News
๐Ÿ“ฐ News12 March 2026ยท2 min readยท

MHRA Approves Deuruxolitinib (Leqselvi) for Severe Alopecia Areata

Source: govuk-visas
MHRA Approves Deuruxolitinib (Leqselvi) for Severe Alopecia Areata
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved deuruxolitinib, marketed as Leqselvi, for the treatment of severe alopecia areata in adults. The approval was announced on 12 March 2026. The MHRA confirmed it will continue to monitor the safety and effectiveness of the drug under close review.
Read full article at govuk-visas โ†’
๐Ÿ’ฌ
Join the Discussion
Discuss in the News thread
๐Ÿ’ฌ zim_news Discussion
Discussing: MHRA Approves Deuruxolitinib (Leqselvi) for Severe...
0/1000
โ† Back to News